Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

R&D In Brief: Imaging Agent Approvals, EULAR Updates, Post-ASCO Cancer Data

Jun 13 2014

• By Lisa LaMotta and Jessica Merrill

Related Content

At J.P. Morgan, Ironwood, Shire and Biogen Idec Contemplate What’s Next

Jan 27 2014

Gadavist Dosing Complexities To Be Handled With Packaging, Not REMS

Mar 15 2011

Biogen Plays It Safe With Pricing Of Hemophilia Drug Alprolix

Apr 21 2014

Oral Dosing May Not Be Enough To Win Speedy Adoption Of Pfizer’s RA Pill <em>Xeljanz</em>

Nov 12 2012

Related Companies

Bayer AG

Navidea Biopharmaceuticals, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

EPIRUS Biopharmaceuticals, Inc.

Johnson & Johnson

TG Therapeutics, Inc.

Johnson & Johnson

Pharmacyclics, Inc.

Eli Lilly and Company

Biogen, Inc.

Bayer AG

Additional Topics

United States Clinical Trials Regulation Approvals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window